• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉疾病患者的非缺血性心肌病基质与室性心动过速。

Nonischemic cardiomyopathy substrate and ventricular tachycardia in the setting of coronary artery disease.

机构信息

Electrophysiology Section, Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

出版信息

Heart Rhythm. 2013 Nov;10(11):1622-7. doi: 10.1016/j.hrthm.2013.08.021. Epub 2013 Aug 22.

DOI:10.1016/j.hrthm.2013.08.021
PMID:23973949
Abstract

BACKGROUND

Patients with coronary artery disease (CAD) may have ventricular tachycardia (VT) from a separate nonischemic process. Catheter ablation in these patients can be misguided by abnormalities of coronary arteries.

OBJECTIVE

To identify (1) the prevalence of unanticipated nonischemic VT in patients with known CAD presenting with VT and (2) the substrate and VT characteristics of this unique subset of patients.

METHODS

We examined consecutive patients referred for VT catheter ablation who had a history of myocardial infarction and angiography documented CAD with presumed ischemic VT. Patients with low-voltage zones and/or VT origin inconsistent with CAD distribution were included for further analysis.

RESULTS

Of 732 patients, 9 (1.2%) (7 men; median age 74 years; ejection fraction 30%) fulfilled inclusion criteria. Endocardial left ventricular scar inconsistent with CAD distribution was found in 8 patients. In 1 patient, only epicardial left ventricular scar was found. The distribution of low voltage (<1.5 mV) was predominantly around the aortic and mitral valves. Thirty-one VTs were induced in 8 patients. Most VTs had right bundle branch block (68%); of these VTs, 67% had an R/S transition zone later than lead V4 consistent with basal VT origin. Epicardial ablation was necessary in 2 patients. During follow-up (30 [25-39] months), 7 of 9 patients (78%) were free of recurrent VT.

CONCLUSIONS

A small but important subgroup of patients with CAD and VT has a nonischemic substrate/etiology for VT. The presence of multiple VTs with basal origin suggests a potential nonischemic perivalvular substrate and possible need for epicardial VT ablation.

摘要

背景

患有冠状动脉疾病 (CAD) 的患者可能因独立的非缺血过程而出现室性心动过速 (VT)。在这些患者中进行导管消融可能会因冠状动脉异常而出现误导。

目的

确定 (1) 已知 CAD 患者出现 VT 时,意外非缺血性 VT 的发生率,以及 (2) 这一独特患者亚群的基质和 VT 特征。

方法

我们检查了连续接受 VT 导管消融治疗的患者,这些患者有心肌梗死病史和血管造影记录的 CAD,并假定为缺血性 VT。包括低电压区和/或 VT 起源与 CAD 分布不一致的患者进行进一步分析。

结果

在 732 名患者中,有 9 名 (1.2%) (7 名男性;中位年龄 74 岁;射血分数 30%) 符合纳入标准。8 名患者的左心室心内膜瘢痕与 CAD 分布不一致。在 1 名患者中,仅发现心外膜左心室瘢痕。低电压 (<1.5 mV) 的分布主要在主动脉瓣和二尖瓣周围。8 名患者中诱导了 31 次 VT。大多数 VT 具有右束支传导阻滞 (68%);其中 67%的 VT 在 V4 导联后存在 R/S 转换区,与基底 VT 起源一致。2 名患者需要心外膜消融。在随访期间(30 [25-39] 个月),9 名患者中的 7 名 (78%) 无复发性 VT。

结论

CAD 和 VT 患者中有一小部分但很重要的亚群具有非缺血性基质/病因的 VT。存在多个起源于基底的 VT 提示存在潜在的非缺血性瓣周基质,并可能需要进行心外膜 VT 消融。

相似文献

1
Nonischemic cardiomyopathy substrate and ventricular tachycardia in the setting of coronary artery disease.冠状动脉疾病患者的非缺血性心肌病基质与室性心动过速。
Heart Rhythm. 2013 Nov;10(11):1622-7. doi: 10.1016/j.hrthm.2013.08.021. Epub 2013 Aug 22.
2
Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation.心脏结节病继发难治性室性心动过速:电生理特征、标测与消融
Heart Rhythm. 2006 Aug;3(8):924-9. doi: 10.1016/j.hrthm.2006.03.031. Epub 2006 Mar 30.
3
Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy.右心室心肌病背景下室性心动过速导管消融治疗的电解剖基质与结果
Circulation. 2004 Oct 19;110(16):2293-8. doi: 10.1161/01.CIR.0000145154.02436.90. Epub 2004 Oct 11.
4
Isolated septal substrate for ventricular tachycardia in nonischemic dilated cardiomyopathy: incidence, characterization, and implications.非缺血性扩张型心肌病患者室性心动过速的孤立性间隔基质:发生率、特征及意义。
Heart Rhythm. 2011 Aug;8(8):1169-76. doi: 10.1016/j.hrthm.2011.03.008. Epub 2011 Mar 8.
5
Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia.非缺血性心肌病和单形性室性心动过速患者的心内膜电生理基质特征
Circulation. 2003 Aug 12;108(6):704-10. doi: 10.1161/01.CIR.0000083725.72693.EA. Epub 2003 Jul 28.
6
Substrate Characterization and Outcome of Catheter Ablation of Ventricular Tachycardia in Patients With Nonischemic Cardiomyopathy and Isolated Epicardial Scar.非缺血性心肌病和孤立心外膜瘢痕患者的室性心动过速导管消融的基质特征和结果。
Circ Arrhythm Electrophysiol. 2021 Dec;14(12):e010279. doi: 10.1161/CIRCEP.121.010279. Epub 2021 Dec 1.
7
Apical ventricular tachycardia morphology in left ventricular nonischemic cardiomyopathy predicts poor transplant-free survival.左室非缺血性心肌病中心尖部室性心动过速形态预示着无移植生存不良。
Heart Rhythm. 2013 May;10(5):621-6. doi: 10.1016/j.hrthm.2012.12.029. Epub 2012 Dec 28.
8
High-density substrate-guided ventricular tachycardia ablation: role of activation mapping in an attempt to improve procedural effectiveness.高密度基质指导下心室性心动过速消融:激活标测在提高手术效果中的作用。
Heart Rhythm. 2013 Dec;10(12):1850-8. doi: 10.1016/j.hrthm.2013.09.059. Epub 2013 Sep 19.
9
Characterization of the phrenic nerve course within the epicardial substrate of patients with nonischemic cardiomyopathy and ventricular tachycardia.非缺血性心肌病和室性心动过速患者心外膜基质内膈神经走行的特征分析
Heart Rhythm. 2009 Jan;6(1):59-64. doi: 10.1016/j.hrthm.2008.09.033. Epub 2008 Oct 10.
10
Substrate-modification using electroanatomical mapping in sinus rhythm to treat ventricular tachycardia in patients with ischemic cardiomyopathy.在窦性心律下使用电解剖标测进行基质改良以治疗缺血性心肌病患者的室性心动过速。
Z Kardiol. 2005 Jul;94(7):453-60. doi: 10.1007/s00392-005-0240-3.

引用本文的文献

1
Characteristics of the phenotype of mixed cardiomyopathy in patients with implantable cardioverter-defibrillators.植入式心脏复律除颤器患者混合性心肌病表型特征。
J Interv Card Electrophysiol. 2024 Jan;67(1):129-137. doi: 10.1007/s10840-023-01577-x. Epub 2023 Jun 5.
2
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.2019 年 HRS/EHRA/APHRS/LAHRS 专家共识声明:导管消融治疗室性心律失常。
J Interv Card Electrophysiol. 2020 Oct;59(1):145-298. doi: 10.1007/s10840-019-00663-3.
3
Coronary PCI revascularization novel treatment of bundle branch reentrant ventricular tachycardia.
冠状动脉PCI血运重建术治疗束支折返性室性心动过速的新方法。
J Cardiol Cases. 2019 Sep 20;20(5):151-154. doi: 10.1016/j.jccase.2019.08.003. eCollection 2019 Nov.
4
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.2019 年 HRS/EHRA/APHRS/LAHRS 专家共识声明:导管消融治疗室性心律失常
Heart Rhythm. 2020 Jan;17(1):e2-e154. doi: 10.1016/j.hrthm.2019.03.002. Epub 2019 May 10.
5
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.2019 年 HRS/EHRA/APHRS/LAHRS 专家共识声明:导管消融治疗室性心律失常。
Europace. 2019 Aug 1;21(8):1143-1144. doi: 10.1093/europace/euz132.
6
Bicuspid aortic valve supporting supravalvular "substrate" for multiple ventricular tachycardias.二叶式主动脉瓣为多种室性心动过速提供瓣上“基质”支持。
HeartRhythm Case Rep. 2017 Jan 14;3(3):155-158. doi: 10.1016/j.hrcr.2016.09.006. eCollection 2017 Mar.
7
Ventricular Tachycardia Ablation - The Right Approach for the Right Patient.室性心动过速消融术——为合适的患者选择正确的方法。
Arrhythm Electrophysiol Rev. 2014 Nov;3(3):161-7. doi: 10.15420/aer.2014.3.3.161. Epub 2014 Nov 29.